Pethidine Anti-Shivering — FRCA Primary MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Pethidine administered as a monitored recovery-room treatment
The best answer is “Pethidine administered as a monitored recovery-room treatment”. Pethidine has a recognised anti-shivering effect and is commonly used for troublesome postoperative shivering in a monitored setting. It still carries opioid adverse effects and is unsuitable for some patients, particularly with renal impairment. The other drugs are not established first-line anti-shivering treatments.
Reference: RCoA, FRCA Primary MCQ examination: https://rcoa.ac.uk/examinations/primary-frca-examination/frca-primary-mcq-examination